Soft Tissue Sarcoma of Extremities: Descriptive Epidemiological Analysis According to National Population-based Study

Document Type : RESEARCH PAPER

Authors

1 1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2 Department of Orthopedic Surgery, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 5 Physiotherapy Research Center, Shahid Beheshti University of Medical Sciences

2 1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2 Department of Orthopedic Surgery, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Department of Orthopedic Surgery, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Biostatics, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

5 2 Department of Orthopedic Surgery, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 5 Physiotherapy Research Center, Shahid Beheshti University of Medical Sciences

6 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract

Background: Soft-Tissue Sarcoma (STS) is a heterogeneous group of neoplasms of mesenchymal origin, occurring in connective tissues. According to previously conducted studies, STS accounts for approximately 1% and 7-%15% of adult and pediatric malignancies, respectively. Almost 50%-60% of sarcomas arise from extremities and usually present as a large painless or rarely painful soft-tissue mass. The present study aimed to describe the epidemiology of soft-tissue sarcomas, especially in the Iranian population. Methods: This epidemiological study of limb soft-tissue sarcoma was conducted based on Iran National Cancer Registry data (INCR) between 2009 and 2014. Patients with soft-tissue sarcoma confirmed by histopathological studies were included, and data were classified based on the International Classification of Diseases for Oncology (first revision-third edition [ICD-O-3]) and analyzed. Descriptive analysis was performed to extract age-standardized and age-specific incidence rates. Results: A total of 2, 593 patients (1,476 males and 1,117 females) were enrolled and assessed in the present study. The age-standardized incidence rate(ASIR) of total soft tissue sarcomas was 6.34 per million person-years. In addition, the highest and lowest ASIR scores stratified by age were observed in patients aged above 65 and under 0 with the value of 19.61 (95% CI:17.91-21.30) and 1.91 (95% CI 1.69, 2.13) per million, respectively. Limb soft tissue sarcomas stratified by gender were dominant in males, and it was statistically significant (P<0.05). The most common extremity soft tissue sarcomas subtypes were mesenchymal tumor (12.26%), spindle cell sarcoma (12.18%), and malignant fibrous histiocytoma (11.45%). Conclusion: As evidenced by the results of the present study, the ASIR of soft tissue sarcoma dramatically increased with age, and the peak ASIR occurred in the age range of above 65 years. The incidence rate of soft tissue sarcomas analyzed by disease site was higher in hip and lower limb than upper limb and pelvis region, and it was detected consistently in all age groups and both genders. Level of evidence: IV

Keywords

References

1. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin. Wiley Online Library; 1993;43(1):7–26.
2. Morrison BA. Soft tissue sarcomas of the extremities. In Baylor University Medical Center Proceedings 2003; 16(3):285-290. Taylor & Francis.
3. Reshadi H, Rouhani A, Mohajerzadeh S, Moosa M, Elmi A. Prevalence of malignant soft tissue tumors in extremities: an epidemiological study in Syria. Archives of Bone and Joint Surgery. 2014;2 (2):106
4. Kang S, Kim H, Choi E, Han I. Incidence and Treatment Pattern of Extremity Soft Tissue Sarcoma in Korea , 2009-2011 : A Nationwide Study Based on the Health Insurance Review and Assessment Service Database. 2015;47(4):575–82.
5. Levi F, La Vecchia C, Randimbison L, Te V-C. Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland. Eur J Cancer. Elsevier; 1999;35(12):1711–6.
6. Ross JA, Severson RK, Davis S, Brooks JJ. Trends in the incidence of soft tissue sarcomas in the United States from 1973 through 1987. Cancer. Wiley Online Library; 1993;72(2):486–90.
7. Schuurman B, Meyer S, Cuesta MA, Nauta JJ. Increasing frequency of soft tissue sarcomas in The Netherlands. Ned Tijdschr Geneeskd. 1992;136(32):1556–60. 8. Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CDM, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int J Cancer. Wiley Online Library; 2006;119(12):2922–30.
9. Wibmer C, Leithner A, Zielonke N, Sperl M, Windhager R. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol. Oxford University Press; 2009;21(5):1106–11.
10. Reshadi H, Rouhani A, Mohajerzadeh S, Moosa M, Elmi A. Prevalence of malignant soft tissue tumors in extremities: an epidemiological study in Syria. Arch Bone Jt Surg. Mashhad University of Medical Sciences; 2014;2(2):106.
11. Rosenthal TC, Kraybill W. Soft tissue sarcomas: integrating primary care recognition with tertiary care center treatment. Am Fam Physician. 1999;60(2):567–72.
12. Gustafson P. Soft tissue sarcoma: epidemiology and prognosis in 508 patients. Acta Orthop Scand. Taylor & Francis; 1994;65(sup259):2–31.
13. Morrison BA. Soft tissue sarcomas of the extremities. InBaylor University Medical Center Proceedings 2003 (Vol. 16, No. 3, pp. 285-290). Taylor & Francis.
14. Bessen T, Caughey GE, Shakib S, Potter JA, Reid J, Farshid G,et al. A population-based study of soft tissue sarcoma incidence and survival in Australia: an analysis of 26,970 cases. Cancer epidemiology. 2019;63:101590.
15. Gingrich AA, Bateni SB, Monjazeb AM, Thorpe SW, Kirane AR, Bold RJ, et al. Extremity soft tissue sarcoma in the elderly: Are we overtreating or undertreating this potentially vulnerable patient population? J Surg Oncol. Wiley Online Library; 2019;119(8):1087–98.
16. Zahm SH, Fraumeni Jr JF. The epidemiology of soft tissue sarcoma. InSeminars in oncology 1997 (Vol. 24, No. 5, pp. 504-514).
17. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin. Wiley Online Library; 1997;47(1):5–27.
18. Pike J, Clarkson PW, Masri BA. Soft tissue sarcomas of the extremities: How to stay out of trouble. BCMJ. 2008;50(6):310–8.
The Archives of Bone and Joint Surgery
Volume 10, Issue 1
January 2022
Pages 67-77

Files

History

  • Receive Date: 24 November 2020
  • Revise Date: 02 March 2021
  • Accept Date: 03 April 2021

Share

How to cite

Statistics